Abaloparatide (Tymlos)_Dosage, benefits & legal status
Also known as Tymlos, BA058
A bone-building drug that completes the family around teriparatide.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is Abaloparatide (Tymlos)?
Plain language first. The technical label stays, but it never stands alone.Overview
A daily injection that builds new bone rather than just slowing its loss. It copies a different hormone from teriparatide and does much the same job.
Abaloparatide, a synthetic analogue of parathyroid hormone-related protein (PTHrP 1-34), acting as an anabolic agent at the PTH1 receptor. FDA-approved 28 April 2017 as Tymlos for postmenopausal women with osteoporosis at high risk of fracture, with later expansion to men. Approval included enhanced pharmacovigilance for osteosarcoma reports, scheduled for reassessment fifteen years after approval.
What it's used for
A daily injection for osteoporosis in people at high risk of fracture.
How does Abaloparatide (Tymlos) work?
What it does in the body, and where.Abaloparatide sits next to teriparatide in this library, and the difference between them is which hormone each copies.
- 01Anabolic, not antiresorptiveMost osteoporosis drugs slow the breakdown of bone. Abaloparatide and teriparatide stimulate new bone formation, which is a different and more demanding thing to achieve.
- 02It copies PTHrP rather than PTHTeriparatide is parathyroid hormone fragment 1-34. Abaloparatide is an analogue of parathyroid hormone-related protein. Both act at the same receptor with different binding behaviour.
- 03Intermittent dosing is the trickContinuous parathyroid hormone signalling breaks bone down. A single daily pulse builds it up. The entire drug class depends on that distinction, which is why the dosing schedule is not negotiable.
- 04The osteosarcoma question shaped the labelRodent studies in this drug class raised bone cancer concerns, and the FDA required enhanced pharmacovigilance for reports of osteosarcoma with abaloparatide, to be reassessed fifteen years after approval.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Postmenopausal osteoporosis at high risk of fractureFDA-approved
- Osteoporosis in men at high risk of fractureFDA-approved
- General bone health or fracture healing outside those settingsnone
How much, and do you cycle it?
The range, and whether you take breaks.Set by the label, once daily. Set by the prescriptionFDA label
This is a prescription drug. Duration and schedule are set by the label and the prescriber, not by a cycling convention.
How long does it stay in the body?
The half-life, and where the figure comes from.Short, dosed once dailyFDA label
The bone-building effect depends on a brief daily pulse of receptor activation rather than continuous exposure.
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
0 / 100 unitsHow do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized Abaloparatide (Tymlos) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.Who should avoid it
- Pregnancy or breastfeeding
- Any condition raising the baseline risk of osteosarcoma, including Paget's disease of bone and prior radiation to the skeleton
- High blood calcium
- Use outside a prescription, where no label governs the dose or the treatment duration
Stop and get help
- Fainting, or dizziness severe enough to cause a fall
- Signs of high blood calcium, including persistent nausea, vomiting, constipation or confusion
- Signs of an allergic reaction, including facial or throat swelling or trouble breathing
- New or persistent bone pain
Common effects
- Dizziness and light-headedness, particularly after the first doses
- Palpitations
- Nausea
- Headache
- Injection site reactions
- Raised blood calcium
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Abaloparatide (Tymlos) approved?
And where the numbers on this page come from.Yes. Abaloparatide (Tymlos) is FDA approved and available on prescription in the United States.
- Approval statusFDA-approved
- RouteUnder the skin (subcutaneous)
- CheckedAugust 2026
What has happened recently
FDA-approved 28 April 2017 as Tymlos for postmenopausal osteoporosis at high risk of fracture, later expanded to men with osteoporosis. Prescription only. The approval included enhanced pharmacovigilance for osteosarcoma reports.
You can compare this against the whole library, or read how to check a seller.
- DoseFrom the drug label. The manufacturer tested this range and a regulator reviewed it.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Reviewed24 August 2026
What else is like Abaloparatide (Tymlos)?
Others in Healing and recovery, side by side.If you're weighing Abaloparatide (Tymlos), it's worth reading Calcitonin (salmon), Ac-SDKP (TB-500 Fragment 1-4), and Regeno blend (BPC-157 / TB-500 / Cartalax) in the same class.
A bone-building drug that completes the family around teriparatide.
- Dose
- Set by the label
- How often
- Once daily
A bone hormone borrowed from salmon, and the weakest option in its own category.
- Dose
- Set by the label
- How often
- Daily, by spray or injection
The first four amino acids of TB-500, and a drug candidate in its own right.
- Dose
- No established human dose
- How often
- No established schedule
The Wolverine blend with a cartilage bioregulator added.
- Dose
- Research only
- How often
- Varies
10What these words mean
Show glossary +
What these words mean
- 503A and 503B
- The two kinds of compounding pharmacy in US law. A 503A pharmacy prepares medicine for one named patient. A 503B outsourcing facility makes larger batches under stricter manufacturing rules.
- Agonist
- Something that switches a receptor on. The opposite is an antagonist. It blocks the receptor instead.
- Amino acid
- The building blocks that link together in a chain to make a peptide or a protein. The order they sit in is what makes one peptide different from another.
- Amylin
- A hormone released alongside insulin that slows the stomach emptying and reduces appetite. Several weight loss compounds copy it.
- Analog
- A compound built to copy a natural one with small deliberate changes, usually so it lasts longer or holds onto its target more tightly.
- Animal study
- Research done in rats, mice or other animals. Most findings do not repeat in people, so an animal result is a reason to keep looking. It is not a reason to act.
- Antibody
- A large immune protein, far bigger than a peptide, engineered to lock onto one specific target. These are made by drug companies and are not sold as research powders.
- Bacteriostatic water
- Sterile water with a tiny amount of preservative, used to mix powdered peptides.
- Banned in drug-tested sport
- Prohibited by the World Anti-Doping Agency (WADA); using it can disqualify a competing athlete.
- Bioavailability
- How much of a dose actually reaches your bloodstream. Most peptides survive stomach acid badly, so most of them are injected instead of swallowed.
- Bioregulator
- Very short peptides from a Russian research tradition, usually two to four amino acids long, sold for supporting a specific organ. Human evidence is thin and most of it is published in Russian.
- Blend
- One vial holding more than one compound, mixed together by the seller. Working out a dose means working out each ingredient separately, because they are rarely present in equal amounts.
- Boxed warning
- The most serious warning the FDA puts on a drug label, printed inside a black border. It flags a risk considered severe enough to sit above everything else on the label.
- Bulks list
- The FDA's list of ingredients that compounding pharmacies are allowed to use. A substance can sit under review on it for years without anything being decided either way.
- Certificate of analysis (COA)
- A lab report on a batch of product. It only means something if it names the batch you actually received, comes from an independent lab, and can be checked with that lab.
- Clinical trial
- A study that gives a treatment to people under a written plan and measures what happens. It is the only kind of evidence that can show something works in humans.
- Compounding
- A licensed pharmacy preparing a medicine to order. Being allowed to compound something is not the same as the FDA approving it, and the two get mixed up constantly.
- Concentration
- How strong the mixed peptide is, in milligrams per milliliter (mg/mL). More water makes it weaker; less water makes it stronger.
- Cycle
- A stretch of time using a compound followed by a break. Most cycling patterns come from community practice. Very few have been tested.
- DAC
- Short for Drug Affinity Complex. An attachment added to a peptide so it grabs onto a blood protein and stays in the body for days instead of minutes.
- Dead space
- The small amount of liquid left sitting inside the needle and hub after you inject. On very small doses it can be a real share of what you meant to take.
- Dilute
- Adding more liquid to make a mix weaker. The amount of peptide in the vial does not change. It is just spread through more water, so each draw is bigger.
- Endpoint
- The result a trial said in advance that it would measure. A study can be reported as positive and still have missed the endpoint it set out to hit.
- FDA approved
- Reviewed by the FDA and cleared for a specific use, in a specific form, at a specific dose. Approval for one use is not approval for another, and approval in another country is not approval here.
- Fragment
- A short piece cut out of a larger natural protein. A fragment can behave very differently from the whole protein it came from, so evidence about one does not transfer to the other.
- Ghrelin
- The hunger hormone. Some growth hormone compounds work by copying it, so they can make you noticeably hungrier.
- GHRH
- A natural signal telling the pituitary gland to release growth hormone. Several compounds copy it.
- GHRP
- A second, separate signal that also triggers growth hormone release, through a different door than GHRH. This is why the two types are often used together.
- GLP-1
- A natural gut hormone that lowers appetite and blood sugar. Drugs that copy it, like semaglutide, are used for weight loss.
- Growth hormone secretagogue
- A compound that nudges your body to release more of its own growth hormone, rather than injecting the hormone itself.
- Half-life
- How long a compound stays active in your body. A longer half-life means you inject less often.
- HPLC
- A lab method that separates out everything in a sample so the amounts can be measured. It shows how much of the main ingredient is there. It does not confirm that the main ingredient is the right molecule.
- In vitro
- Done in a dish or a test tube, on cells outside a living body. It is the earliest kind of evidence there is.
- Injection site
- The spot on the body where you inject. Moving it around gives the skin and fat underneath time to recover between doses.
- Intramuscular (IM)
- An injection into a muscle, using a longer needle.
- Intravenous (IV)
- An injection into a vein. It needs training and equipment and is not something to do at home.
- Investigational
- Still being tested in clinical trials and not yet approved or legally sold for general use.
- Lyophilized
- Freeze-dried into a powder so it keeps longer. That is the white cake or dust in the bottom of an unmixed vial.
- Mass spectrometry
- A lab method that weighs molecules to confirm what they are. HPLC answers how much is in the sample. This answers what it is.
- mcg and mg
- Units of dose. 1 milligram (mg) equals 1,000 micrograms (mcg).
- Myostatin
- A natural brake on muscle growth. Several compounds are built to block it, though human results have been far smaller than the animal work suggested.
- Off-label
- A doctor prescribing an approved drug for something other than its approved use. This is legal and common, and it is different from a compound having no approval at all.
- Orphan drug designation
- A status given to treatments for rare conditions to make them worth developing. It is an incentive, not an approval, and a compound can hold it while being approved for nothing.
- PCAC
- The FDA advisory committee that reviews compounding ingredients. It recommends. It does not approve, and the FDA does not have to follow what it says.
- Peer review
- Other scientists checking a paper before a journal publishes it. It filters out some bad work. It does not make a finding true.
- Peptide vs small molecule
- A peptide is a short chain of amino acids. A few items here (like MK-677 or methylene blue) are small molecules, not true peptides, but people use them the same way.
- Placebo
- A dummy treatment given for comparison. Without one it is very hard to tell a real effect apart from expectation and time passing.
- Purity
- The share of a sample that is the intended compound, usually given as a percentage. A high purity number on the wrong molecule is still the wrong molecule.
- Randomized
- Deciding by chance who gets which treatment, so the two groups are comparable. Studies that skip this are much easier to read the wrong way.
- Receptor
- A docking point on a cell that a compound attaches to. If a cell has no matching receptor, the compound does nothing to it.
- Reconstitution
- Mixing a powdered peptide with liquid (bacteriostatic water) so it can be drawn into a syringe.
- Research only
- No approved dose or use in people. Sold for research and not reviewed by the FDA for safety or quality.
- Stack
- Using more than one compound at the same time. Almost no combinations have been tested together in people, so a stack is usually built on guesswork.
- Sterile water
- Water with nothing added to stop bacteria growing. It works for a single dose, but a vial mixed with it should not be kept and used again.
- Subcutaneous
- An injection just under the skin, into the fat layer, usually with a short, thin insulin needle.
- Titrate
- Starting at a low dose and increasing it slowly over time so your body adjusts and side effects stay mild.
- Trial phases
- The stages of human testing. Phase 1 checks safety in a small group, phase 2 looks for an effect, and phase 3 tests it against a comparison in a large group.
- Units (on the syringe)
- The marks on an insulin syringe. 100 units equals 1 mL. They measure how much liquid you draw, not the dose in milligrams.
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
Last reviewed 24 August 2026
Peptide Decoding is published by Decoded Sciences LLC. We take no payment from vendors for coverage, inclusion or ranking, and our affiliate relationships are disclosed in full.